![Quiver Logo](/static/img/logo-icon.png)
![AEON logo](https://quiver-logos.s3.us-east-2.amazonaws.com/aeon.png)
AEON Biopharma, Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AEON Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of AEON by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AEON's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to AEON
Recent picks made for AEON stock on CNBC
ETFs with the largest estimated holdings in AEON
Flights by private jets registered to AEON
![Quiver Logo](/static/img/logo-icon.png)